What does this TikTok actually claim?
Madison Mulkey shares her personal experience using semaglutide (the active ingredient in Ozempic and Wegovy) for weight loss. She describes herself as someone with food addiction who finally found something that "made a difference."
The video is responsible in its disclaimers. She explicitly states she's not a doctor and is sharing personal experience rather than medical advice. This kind of transparency is refreshing on a platform where health misinformation spreads quickly.
The hashtags suggest she's using semaglutide through a weight management program, possibly combining it with other approaches like Weight Watchers. This multimodal approach matches how these medications are typically prescribed.
Does her experience match clinical data?
Madison's positive response to semaglutide is consistent with large-scale clinical trials. The STEP 1 trial (Wilding et al., NEJM, 2021) found that 68 weeks of 2.4mg semaglutide led to 14.9% average body weight loss compared to 2.4% with placebo.
What's particularly relevant is her mention of food addiction. Semaglutide works by activating GLP-1 receptors in the brain that regulate appetite and food intake. The STEP 1 trial showed 86.4% of participants lost at least 5% of their body weight, suggesting most people do see meaningful results.
Her experience isn't unique or surprising based on the data. The medication has shown consistent efficacy across multiple large trials, though individual responses vary significantly.
What doesn't she mention that matters?
Madison's brief video skips several important realities about semaglutide treatment. She doesn't discuss side effects, which affected 74.2% of participants in STEP 1 trials, mostly gastrointestinal issues like nausea and diarrhea.
There's no mention of the medication's cost, which runs roughly $1,200-$1,500 monthly without insurance coverage. Many insurance plans don't cover semaglutide for weight loss, making it inaccessible for many patients.
She also doesn't address what happens when you stop taking it. The STEP 1 withdrawal extension study showed participants regained about two-thirds of their lost weight within a year of stopping treatment. This isn't a short-term fix.
Should you trust this kind of content?
Madison's approach is more trustworthy than most health TikToks because she includes clear disclaimers and doesn't make medical claims. She's sharing personal experience, not giving advice.
However, success stories can create unrealistic expectations. While semaglutide is effective for most people, the STEP trials also showed that 13.6% of participants didn't achieve even 5% weight loss. Individual results really do vary.
The real issue isn't with Madison's content but with how viewers might interpret it. Personal testimonials, no matter how honest, can't replace conversations with healthcare providers about whether this medication is appropriate for your specific situation.